| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT06993480 A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in… |
date change Primary completion pushed: 2026-07-17 -> 2027-07-27 |
| 2026-08-11 | NCT06993480 A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in… |
date change Completion pushed: 2027-02-09 -> 2027-11-27 |
| 2026-08-06 | NCT07137910 A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With… |
Enrollment increased: 60 -> 200 participants |
| 2026-08-06 | NCT07137910 A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With… |
Trial arms changed: 2 -> 3 |
| 2026-08-06 | NCT07137910 A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With… |
Trial sites expanded: 1 -> 12 locations |
| 2026-07-30 | NCT07146100 Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB)… |
Trial sites expanded: 2 -> 8 locations |
| 2026-07-30 | NCT07069569 A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs |
Trial sites expanded: 1 -> 14 locations |
| 2026-07-30 | NCT07600788 A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137… |
Recruitment opened |
| 2026-07-30 | NCT07600788 A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137… |
Trial sites expanded: 1 -> 5 locations |
| 2026-07-30 | NCT07635186 A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic… |
Recruitment opened |
| 2026-07-30 | NCT07635186 A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic… |
Trial sites expanded: 2 -> 34 locations |
| 2026-07-22 | NCT07630727 Study of AHB-171 in Chronic Hepatitis B Participants |
Trial sites expanded: 1 -> 10 locations |
| 2026-07-22 | NCT07511218 A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B… |
Primary endpoint(s) modified |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07246889 | Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With… | Chronic Hepatitis B | Active, Not Recruiting |
| Phase 2 | |||
| NCT07630727 | Study of AHB-171 in Chronic Hepatitis B Participants | Hepatitis B, Chronic (CHB) | Recruiting |
| NCT07069569 | A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs | Chronic Hepatitis B | Recruiting |
| NCT07635186 | A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic… | Chronic Hepatitis B | Recruiting |
| NCT07137910 | A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With… | Chronic Hepatitis B | Recruiting |
| NCT06550128 | Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With… | Hepatitis B, Chronic | Active, Not Recruiting |
| NCT06829329 | Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With… | Chronic Hepatitis B | Active, Not Recruiting |
| NCT06993480 | A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in… | Chronic Hepatitis B | Active, Not Recruiting |
| Phase 1 | |||
| NCT07511218 | A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B… | Chronic Hepatitis B Infection | Recruiting |
| NCT07600788 | A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137… | Chronic Hepatitis B | Recruiting |
| Not specified | |||
| NCT07146100 | Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB)… | Chronic Hepatitis B | Recruiting |